Payers deny cancer treatments that should be approved — and count on your staff being too busy to fight back. VerityAuth gets PAs approved faster, appeals every denial with NCCN-cited evidence, and leaves zero patients behind.
The gap between those two numbers is the entire broken system in one stat. VerityAuth closes it.
When a PA is denied, 88% of the time nobody appeals — not because the denial is clinically justified, but because your coordinator has 30 other PAs in the queue and no time to draft a letter, pull NCCN citations, and sit on hold with a medical director. Payers know this.
Yet 80% of appeals succeed when someone actually files one — which means most denied treatments should have been approved in the first place. Every unappealed denial costs your practice three ways:
Treatment delayed. Second-choice drugs substituted. 93% of oncologists report forced substitutions, and delays of even 1–3 weeks correlate with worse disease control and lower survival.
Cancer Therapy Advisor · Johns Hopkins MedicineCoordinators spend 12+ hours a week in payer portals, chasing faxes, and sitting on hold. With 30 PAs in the queue, there's no time to appeal — so the denial stands.
AMA Prior Authorization Physician Survey, 2024$10K–$50K per denial, written off because nobody had time to fight it. Across 6–10 denials a month, that's the largest recoverable revenue leak in your practice.
Typical specialty drug & radiation reimbursement97% of radiation treatments and most infusion drugs require PA. A single cancer patient needs 6–15 separate authorizations across drugs, imaging, radiation, procedures, devices, and supportive care — each one a chance for a denial nobody has time to appeal. Generic PA tools treat a Keytruda auth like an MRI for back pain. Your patients are on timelines measured in days.
VerityAuth was built oncology-first by people who've lived inside the PA maze for over a decade — on the provider side, the technology side, and the payer side.
AI matches regimens to current NCCN guidelines with evidence level and category citations.
Understands multi-drug regimens, lines of therapy, and step therapy requirements specific to oncology.
When a denial stands, AI searches ClinicalTrials.gov for eligible trials — turning a dead end into an alternative path.
Designed for the 3–15 provider groups that treat the majority of cancer patients but get ignored by enterprise vendors.
Every oncology PA — drug, imaging, radiation, procedure, device, supportive care — follows the same streamlined path.
Select the PA type, patient, and payer. AI handles the rest.
Category-specific clinical forms for all 6 PA types. Related PAs auto-link and pre-fill from each other — because every resubmission is another delay a cancer patient can't afford.
Before you enter the PA maze, check whether you can skip it entirely.
Real-time eligibility across 3,400+ payers — and the AI flags clinically equivalent drugs the payer covers without PA, with NCCN equivalence shown.
The form fills itself — checked against payer criteria and NCCN guidelines.
Instead of 30+ manual fields, AI pre-populates everything from the clinical profile, scores approval probability, and flags documentation gaps before you submit.
Your entire PA operation in one command center.
Replaces the spreadsheets and sticky notes with automatic tracking of every call, fax, and status change — freeing your team to do the work that recovers revenue: fighting denials.
88% of denials go uncontested. VerityAuth fights every one.
The system generates an NCCN-cited appeal letter and P2P talking points in 2 minutes. At $10K–$50K per denial and an 80% overturn rate, that's the ROI conversation in one sentence. And if the appeal fails, the patient is already matched to eligible clinical trials.
Dedicated coordinator, office manager wearing another hat, or a clinician doing it all — VerityAuth adapts to how your team actually works.



Your practice already has denials every month that nobody appeals. VerityAuth appeals all of them. The numbers do the rest.
A single $35K appeal win covers the entire annual subscription. Everything after that is recovered revenue your practice was writing off.
Every overturned denial is a patient who receives the treatment their oncologist actually prescribed — not the second-choice therapy the payer substituted.
No installation, no EHR integration, no IT department required.
Create your practice profile, add providers, connect payer portal credentials. It's a web app — nothing to install.
15 minutesChoose the PA type, enter clinical details in category-specific forms, and see approval probability before you submit.
5 minutes per PAEvery PA monitored in one place. If denied, AI generates the appeal and finds clinical trial alternatives.
AutomatedSimple per-provider pricing. All features included. No tiers, no add-ons, no implementation fees.
30 days free · No credit card · No obligation
Security and compliance aren't features. They're the foundation.
What oncology practices want to know before getting started.
VerityAuth supports eligibility verification across 3,400+ payers through our Stedi integration. PA submissions work with all commercial payers and Medicare. We add payer-specific criteria as customers need them.
No. VerityAuth is a standalone web application — no installation, no EHR integration, no IT involvement. Your staff logs in from any browser and starts submitting PAs immediately. EHR integration is on our v2 roadmap.
Most PA tools automate form-filling for drug PAs only. VerityAuth covers all 6 PA types with category-specific clinical forms, links related PAs so your staff enters patient data once, and includes a full coordination workspace — activity logs, reminders, team assignment, and supervisor dashboards. The AI understands clinical content: matching regimens to NCCN guidelines, predicting approval likelihood, and generating evidence-based appeals.
Yes. All data is encrypted in transit (TLS 1.2+) and at rest (AES-256). We run on HIPAA-eligible AWS infrastructure and provide a signed BAA for every customer. We never use patient data to train AI models.
Simple per-provider monthly subscription. All features included — no per-PA fees, no setup costs, no hidden charges. We'll walk through pricing during your demo so we can tailor it to your practice size. The pilot period is completely free.
Yes. If your staff can use a payer portal, they can use VerityAuth. We also provide a guided onboarding session and an in-app AI copilot for questions.
CMS is requiring payers to support electronic prior authorization by 2027. Practices that adopt electronic PA tools now will be ahead of the curve — and tools like VerityAuth will become essential infrastructure.
Both — and that's the point. Faster PA processing means faster treatment starts. Every denial gets appealed with NCCN-backed evidence, so patients get the drug you prescribed instead of a second-choice alternative. Clinical trial matching turns final denials into new options. And the platform tracks clinical impact from day one — turnaround time, forced substitutions avoided, appeals won.
The stats we cite — denial rates, appeal success rates, and clinical impact data — come from KFF's Medicare Advantage analysis, the AMA's Prior Authorization Physician Survey, ASCO policy statements, ASTRO surveys, and published research from Johns Hopkins Medicine.
Every week is another round of denials that go uncontested, revenue that walks out the door, and patients who don't get the treatment you prescribed. Tell us about your practice, or jump straight into the live demo.
We walk you through the platform on a short call with your own payer mix and drugs in mind, then give you a private access code so your team can explore it themselves.